Achieve Life Sciences, Inc.ACHVNASDAQ
LOADING
|||
Net Income Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year net income growth rate
Latest
-13.55%
↓ 32% below average
Average (39q)
-10.27%
Historical baseline
Range
High:62.15%
Low:-115.95%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -13.55% |
| Q2 2025 | 0.85% |
| Q1 2025 | -3.78% |
| Q4 2024 | 1.21% |
| Q3 2024 | -47.88% |
| Q2 2024 | -30.29% |
| Q1 2024 | -18.59% |
| Q4 2023 | 22.96% |
| Q3 2023 | 13.73% |
| Q2 2023 | 8.37% |
| Q1 2023 | 19.94% |
| Q4 2022 | 14.11% |
| Q3 2022 | -24.92% |
| Q2 2022 | -38.23% |
| Q1 2022 | -5.90% |
| Q4 2021 | -6.87% |
| Q3 2021 | 40.85% |
| Q2 2021 | -41.41% |
| Q1 2021 | -69.33% |
| Q4 2020 | -25.50% |
| Q3 2020 | -28.82% |
| Q2 2020 | 11.99% |
| Q1 2020 | -3.94% |
| Q4 2019 | 13.04% |
| Q3 2019 | -1.35% |
| Q2 2019 | 38.62% |
| Q1 2019 | -62.33% |
| Q4 2018 | -12.25% |
| Q3 2018 | -16.21% |
| Q2 2018 | 7.74% |
| Q1 2018 | 19.20% |
| Q4 2017 | 42.21% |
| Q3 2017 | -115.95% |
| Q2 2017 | 8.32% |
| Q1 2017 | 44.05% |
| Q4 2016 | -58.35% |
| Q3 2016 | 46.44% |
| Q2 2016 | -85.84% |
| Q1 2016 | -115.27% |
| Q4 2015 | 62.15% |